Bio

Celltrion founder aims to raise $1 bn for healthcare startup from global funds

Woo-sub Kim

Oct 07, 2020 (Gmt+09:00)

Seo Jung-jin, founder and chairman of South Korea’s biosimilar maker Celltrion Group, said on Oct. 6 that he is in talks with a number of global investment funds to raise about $1 billion for an overseas healthcare startup he plans to launch early next year.

The firm, set to join the emerging sector of medical technology known as ubiquitous healthcare, will be based in a foreign country. It will provide remote medical services whereby a patient can undergo medical checks sending in ...

More To Read